The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Emergency Contraceptives-Global Market Insights and Sales Trends 2025
Synopsis
The emergency contraceptives market refers to the industry involved in the production, distribution, and sale of medications and products used for emergency contraception. Emergency contraceptives, also known as "morning-after pills," are designed to prevent pregnancy after unprotected intercourse or contraceptive failure.
The global Emergency Contraceptives market size is expected to reach US$ 936.7 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Emergency Contraceptives in various end use industries. The expanding demands from the Hospital pharmacies, Retail pharmacies, Online pharmacies and Others, are propelling Emergency Contraceptives market. Combined Estrogen and Progestin Pills, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Progestin-Only (As Levonorgestrel) Pills segment is estimated at % CAGR for the next seven-year period.
The emergency contraceptives market is a segment within the broader contraceptive industry. It focuses on providing women with safe and effective options for emergency contraception when regular contraceptive methods have failed, were not used, or in cases of sexual assault.
The emergency contraceptives market is influenced by factors such as changing societal norms, increasing awareness of contraception options, rising demand for reproductive healthcare services, and initiatives to reduce unintended pregnancies. Additionally, the market is driven by advancements in emergency contraceptive formulations and the expansion of distribution channels.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Emergency Contraceptives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Emergency Contraceptives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Emergency Contraceptives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Emergency Contraceptives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Emergency Contraceptives covered in this report include Genetics, Teva Pharmaceutical, Uniprix, Gavis Pharmaceuticals, HRA Pharma and Mankind Pharma, etc.
The global Emergency Contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
Global Emergency Contraceptives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Emergency Contraceptives market, Segment by Type:
Combined Estrogen and Progestin Pills
Progestin-Only (As Levonorgestrel) Pills
Antiprogestin (As Mifepristone) Pills
Ulipristal Acetate Pills
Global Emergency Contraceptives market, by Application
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Emergency Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Emergency Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The emergency contraceptives market refers to the industry involved in the production, distribution, and sale of medications and products used for emergency contraception. Emergency contraceptives, also known as "morning-after pills," are designed to prevent pregnancy after unprotected intercourse or contraceptive failure.
The global Emergency Contraceptives market size is expected to reach US$ 936.7 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Emergency Contraceptives in various end use industries. The expanding demands from the Hospital pharmacies, Retail pharmacies, Online pharmacies and Others, are propelling Emergency Contraceptives market. Combined Estrogen and Progestin Pills, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Progestin-Only (As Levonorgestrel) Pills segment is estimated at % CAGR for the next seven-year period.
The emergency contraceptives market is a segment within the broader contraceptive industry. It focuses on providing women with safe and effective options for emergency contraception when regular contraceptive methods have failed, were not used, or in cases of sexual assault.
The emergency contraceptives market is influenced by factors such as changing societal norms, increasing awareness of contraception options, rising demand for reproductive healthcare services, and initiatives to reduce unintended pregnancies. Additionally, the market is driven by advancements in emergency contraceptive formulations and the expansion of distribution channels.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Emergency Contraceptives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Emergency Contraceptives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Emergency Contraceptives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Emergency Contraceptives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Emergency Contraceptives covered in this report include Genetics, Teva Pharmaceutical, Uniprix, Gavis Pharmaceuticals, HRA Pharma and Mankind Pharma, etc.
The global Emergency Contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
Global Emergency Contraceptives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Emergency Contraceptives market, Segment by Type:
Combined Estrogen and Progestin Pills
Progestin-Only (As Levonorgestrel) Pills
Antiprogestin (As Mifepristone) Pills
Ulipristal Acetate Pills
Global Emergency Contraceptives market, by Application
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Emergency Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Emergency Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Emergency Contraceptives Market Overview
1.1 Emergency Contraceptives Product Overview
1.2 Emergency Contraceptives Market Segment by Type
1.2.1 Combined Estrogen and Progestin Pills
1.2.2 Progestin-Only (As Levonorgestrel) Pills
1.2.3 Antiprogestin (As Mifepristone) Pills
1.2.4 Ulipristal Acetate Pills
1.3 Global Emergency Contraceptives Market Size by Type
1.3.1 Global Emergency Contraceptives Market Size Overview by Type (2018-2029)
1.3.2 Global Emergency Contraceptives Historic Market Size Review by Type (2018-2023)
1.3.3 Global Emergency Contraceptives Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Emergency Contraceptives Sales Breakdown by Type (2018-2023)
1.4.2 Europe Emergency Contraceptives Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Emergency Contraceptives Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Emergency Contraceptives Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Emergency Contraceptives Sales Breakdown by Type (2018-2023)
2 Global Emergency Contraceptives Market Competition by Company
2.1 Global Top Players by Emergency Contraceptives Sales (2018-2023)
2.2 Global Top Players by Emergency Contraceptives Revenue (2018-2023)
2.3 Global Top Players by Emergency Contraceptives Price (2018-2023)
2.4 Global Top Manufacturers Emergency Contraceptives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Emergency Contraceptives Market Competitive Situation and Trends
2.5.1 Emergency Contraceptives Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Emergency Contraceptives Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Emergency Contraceptives as of 2022)
2.7 Date of Key Manufacturers Enter into Emergency Contraceptives Market
2.8 Key Manufacturers Emergency Contraceptives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Emergency Contraceptives Status and Outlook by Region
3.1 Global Emergency Contraceptives Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Emergency Contraceptives Historic Market Size by Region
3.2.1 Global Emergency Contraceptives Sales in Volume by Region (2018-2023)
3.2.2 Global Emergency Contraceptives Sales in Value by Region (2018-2023)
3.2.3 Global Emergency Contraceptives Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Emergency Contraceptives Forecasted Market Size by Region
3.3.1 Global Emergency Contraceptives Sales in Volume by Region (2024-2029)
3.3.2 Global Emergency Contraceptives Sales in Value by Region (2024-2029)
3.3.3 Global Emergency Contraceptives Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Emergency Contraceptives by Application
4.1 Emergency Contraceptives Market Segment by Application
4.1.1 Hospital pharmacies
4.1.2 Retail pharmacies
4.1.3 Online pharmacies
4.1.4 Others
4.2 Global Emergency Contraceptives Market Size by Application
4.2.1 Global Emergency Contraceptives Market Size Overview by Application (2018-2029)
4.2.2 Global Emergency Contraceptives Historic Market Size Review by Application (2018-2023)
4.2.3 Global Emergency Contraceptives Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Emergency Contraceptives Sales Breakdown by Application (2018-2023)
4.3.2 Europe Emergency Contraceptives Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Emergency Contraceptives Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Emergency Contraceptives Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Emergency Contraceptives Sales Breakdown by Application (2018-2023)
5 North America Emergency Contraceptives by Country
5.1 North America Emergency Contraceptives Historic Market Size by Country
5.1.1 North America Emergency Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Emergency Contraceptives Sales in Volume by Country (2018-2023)
5.1.3 North America Emergency Contraceptives Sales in Value by Country (2018-2023)
5.2 North America Emergency Contraceptives Forecasted Market Size by Country
5.2.1 North America Emergency Contraceptives Sales in Volume by Country (2024-2029)
5.2.2 North America Emergency Contraceptives Sales in Value by Country (2024-2029)
6 Europe Emergency Contraceptives by Country
6.1 Europe Emergency Contraceptives Historic Market Size by Country
6.1.1 Europe Emergency Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Emergency Contraceptives Sales in Volume by Country (2018-2023)
6.1.3 Europe Emergency Contraceptives Sales in Value by Country (2018-2023)
6.2 Europe Emergency Contraceptives Forecasted Market Size by Country
6.2.1 Europe Emergency Contraceptives Sales in Volume by Country (2024-2029)
6.2.2 Europe Emergency Contraceptives Sales in Value by Country (2024-2029)
7 Asia-Pacific Emergency Contraceptives by Region
7.1 Asia-Pacific Emergency Contraceptives Historic Market Size by Region
7.1.1 Asia-Pacific Emergency Contraceptives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Emergency Contraceptives Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Emergency Contraceptives Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Emergency Contraceptives Forecasted Market Size by Region
7.2.1 Asia-Pacific Emergency Contraceptives Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Emergency Contraceptives Sales in Value by Region (2024-2029)
8 Latin America Emergency Contraceptives by Country
8.1 Latin America Emergency Contraceptives Historic Market Size by Country
8.1.1 Latin America Emergency Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Emergency Contraceptives Sales in Volume by Country (2018-2023)
8.1.3 Latin America Emergency Contraceptives Sales in Value by Country (2018-2023)
8.2 Latin America Emergency Contraceptives Forecasted Market Size by Country
8.2.1 Latin America Emergency Contraceptives Sales in Volume by Country (2024-2029)
8.2.2 Latin America Emergency Contraceptives Sales in Value by Country (2024-2029)
9 Middle East and Africa Emergency Contraceptives by Country
9.1 Middle East and Africa Emergency Contraceptives Historic Market Size by Country
9.1.1 Middle East and Africa Emergency Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Emergency Contraceptives Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Emergency Contraceptives Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Emergency Contraceptives Forecasted Market Size by Country
9.2.1 Middle East and Africa Emergency Contraceptives Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Emergency Contraceptives Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Genetics
10.1.1 Genetics Company Information
10.1.2 Genetics Introduction and Business Overview
10.1.3 Genetics Emergency Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Genetics Emergency Contraceptives Products Offered
10.1.5 Genetics Recent Development
10.2 Teva Pharmaceutical
10.2.1 Teva Pharmaceutical Company Information
10.2.2 Teva Pharmaceutical Introduction and Business Overview
10.2.3 Teva Pharmaceutical Emergency Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Pharmaceutical Emergency Contraceptives Products Offered
10.2.5 Teva Pharmaceutical Recent Development
10.3 Uniprix
10.3.1 Uniprix Company Information
10.3.2 Uniprix Introduction and Business Overview
10.3.3 Uniprix Emergency Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Uniprix Emergency Contraceptives Products Offered
10.3.5 Uniprix Recent Development
10.4 Gavis Pharmaceuticals
10.4.1 Gavis Pharmaceuticals Company Information
10.4.2 Gavis Pharmaceuticals Introduction and Business Overview
10.4.3 Gavis Pharmaceuticals Emergency Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Gavis Pharmaceuticals Emergency Contraceptives Products Offered
10.4.5 Gavis Pharmaceuticals Recent Development
10.5 HRA Pharma
10.5.1 HRA Pharma Company Information
10.5.2 HRA Pharma Introduction and Business Overview
10.5.3 HRA Pharma Emergency Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.5.4 HRA Pharma Emergency Contraceptives Products Offered
10.5.5 HRA Pharma Recent Development
10.6 Mankind Pharma
10.6.1 Mankind Pharma Company Information
10.6.2 Mankind Pharma Introduction and Business Overview
10.6.3 Mankind Pharma Emergency Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mankind Pharma Emergency Contraceptives Products Offered
10.6.5 Mankind Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Emergency Contraceptives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Emergency Contraceptives Industrial Chain Analysis
11.4 Emergency Contraceptives Market Dynamics
11.4.1 Emergency Contraceptives Industry Trends
11.4.2 Emergency Contraceptives Market Drivers
11.4.3 Emergency Contraceptives Market Challenges
11.4.4 Emergency Contraceptives Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Emergency Contraceptives Distributors
12.3 Emergency Contraceptives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
